Evaluation of Non-B Non-C Liver Cirrhosis in A EL-Rajhi Assuit University Hospital: A Retrospective-Prospective Study
- Conditions
- Non-B Non-C Liver Cirrhosis
- Registration Number
- NCT05314270
- Lead Sponsor
- Assiut University
- Brief Summary
To study the etiologies of patients diagnosed as non-B, non-C liver cirrhosis (NBNC-LC).
To describe the different patient's outcomes.
- Detailed Description
Liver cirrhosis is the ultimate fate of many hepatic insults that may be viral, immunologic, and metabolic or even cryptogenic. (Tsochatzis EA et al., 2014)
Recently, Non-Alcoholic Fatty Liver Disease (NAFLD) present a serious health burden worldwide that affects around 25% of the global adult population with a prevalence of around 31.8% in the Middle East. (Younossi ZM, et al., 2019)
Most of Egyptian patients presented with end-stage liver disease are secondary to post-hepatitic cirrhosis is estimated to be more than 80% of cases. (Guerra J et al., 2012)
The real profile of non-B, non-C etiologies of liver cirrhosis, in Egyptian patients, is still not fully evaluated.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- All pateints diagnosed as Non-B Non-C Liver Cirrhosis in the period from 2017_2023
- We will exclude the pateints that will be diagnosed as HBV-HCV induced Liver Cirrosis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection of different etiologies of liver cirrhosis that not related to HBV or HCV in our community Base line
- Secondary Outcome Measures
Name Time Method Detection of the most common etiologies of Non B Non C liver cirrhosis in our community Baseline